Holen Sie sich die Stockscreener-App
6.78
5.44%
0.35
Vorhandelsmarkt:
6.81
0.03
+0.44%
Schlusskurs vom Vortag:
$6.43
Offen:
$6.37
24-Stunden-Volumen:
733.10K
Relative Volume:
1.87
Marktkapitalisierung:
$127.21M
Einnahmen:
$109.43M
Nettoeinkommen (Verlust:
$5.13M
KGV:
26.02
EPS:
0.2606
Netto-Cashflow:
$18.91M
1W Leistung:
+2.42%
1M Leistung:
-11.26%
6M Leistung:
-63.17%
1J Leistung:
-24.67%
1-Tages-Spanne:
$6.29
$6.86
1-Wochen-Bereich:
$5.94
$6.86
52-Wochen-Spanne:
$5.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.78 | 127.21M | 109.43M | 5.13M | 18.91M | 0.2606 |
VEEV
Veeva Systems Inc
|
179.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
48.83 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.31 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.10 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.03 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
If You Invested $1,000 in Optimizerx Corp (OPRX) - Stock Titan
Best Value Stocks to Buy for March 24th - sharewise.com
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN
Strength seen in OptimizeRx (OPRX): Can its 7.5% jump turn into more strength? - MSN
Guidance Update: Can OptimizeRx Corporation sustain earnings growthEntry Point & Fast Entry Momentum Alerts - baoquankhu1.vn
OPRX Technical Analysis & Stock Price Forecast - Intellectia AI
How The OptimizeRx (OPRX) Narrative Is Shifting As Guidance Resets And Valuation Expectations Reprice - Yahoo Finance
OptimizeRx Corp. (NASDAQ:OPRX) Short Interest Down 16.4% in February - MarketBeat
Is OptimizeRx (OPRX) Stock Undervalued Right Now? - Yahoo Finance
Best Value Stocks to Buy for March 16th - The Globe and Mail
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - MSN
OptimizeRx Corp. (OPRX) Q4 earnings and revenues beat estimates - MSN
OptimizeRx (OPRX) outlines AI-driven pharma marketing strategy and key risks - Stock Titan
Should you sell your OptimizeRx stock? - Cantech Letter
OptimizeRx Corporation Common Stock OPRX ) Stock Price Today & Analysis - Gotrade
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
OptimizeRx (OPRX) Q4 Profitability Turn Challenges Skeptical Earnings Narratives - simplywall.st
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $20.00 by Analysts at Lake Street Capital - MarketBeat
OptimizeRx (NASDAQ:OPRX) Price Target Cut to $18.00 by Analysts at Roth Mkm - MarketBeat
OptimizeRx Warns Of Volatility From 'Most Favored Nation' Pricing Uncertainty - Bitget
Assessing OptimizeRx: Insights From 4 Financial Analysts - Benzinga
B. Riley Financial Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX) - MarketBeat
OptimizeRx (OPRX) Target Price Lowered by Stephens & Co. | OPRX Stock News - GuruFocus
Stephens Cuts OptimizeRx (NASDAQ:OPRX) Price Target to $10.00 - MarketBeat
OptimizeRx (NASDAQ:OPRX) Announces Quarterly Earnings Results - MarketBeat
Stephens cuts OptimizeRx stock price target on soft pharma budgets - Investing.com Nigeria
OptimizeRx Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript - AOL.com
Stephens cuts OptimizeRx stock price target on soft pharma budgets By Investing.com - Investing.com UK
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
OptimizeRx Q4 Earnings Call Highlights - MarketBeat
Stock Repurchase Plan Initiated by OptimizeRx (NASDAQ:OPRX) Board of Directors - MarketBeat
From loss to profit: OptimizeRx posts record $109.4M sales and $10M buyback - Stock Titan
Earnings call transcript: OptimizeRx Q4 2025 earnings beat expectations amid cautious market - Investing.com
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
OPTIMIZERx earnings beat by $0.29, revenue topped estimates - Investing.com Canada
UPDATEOptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Optimizerx Corp enters amendment no. 4 to financing agreementSEC filing - marketscreener.com
OptimizeRx Reports Strong Q4 2025 Results with Record Net Income and Adjusted EBITDA, Updates 2026 Revenue Guidance and Announces Share Repurchase Program - Quiver Quantitative
Optimizerx Corp Enters Amendment No. 4 To Financing Agreement- SEC Filing - TradingView
OptimizeRx Q4 Adjusted Earnings Rise; Reports Buyback Program - marketscreener.com
Geopolitics Watch: Can OptimizeRx Corporation sustain earnings growthTrade Performance Summary & Smart Money Movement Tracker - baoquankhu1.vn
OptimizeRx Corporation (OPRX) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
OptimizeRx Authorizes $10 Million Share Repurchase Program - TipRanks
OptimizeRx (Nasdaq: OPRX) returns to profit and unveils $10M share repurchase plan - Stock Titan
OptimizeRx Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 P.m. ET - 富途牛牛
Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q4 2025 Result - GuruFocus
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.50%
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):